Suchergebnisse - "Shirbint, Emanuel"

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021 von Achiron, Anat, Dolev, Mark, Menascu, Shay, Zohar, Daniela-Noa, Dreyer-Alster, Sapir, Miron, Shmuel, Shirbint, Emanuel, Magalashvili, David, Flechter, Shlomo, Givon, Uri, Guber, Diana, Stern, Yael, Polliack, Michael, Falb, Rina, Gurevich, Michael

“… Since vaccination against coronavirus disease 2019 (COVID-19) became available, risks related to vaccinating patients with multiple sclerosis (MS) need to be …”
Weitere Angaben

Development of an interactive biosensing application for assessing finger dexterity von Abrahami, Michal Greenberg, Warszawer, Yehuda, Kalron, Alon, Shirbint, Emanuel, Didikin, Maria, Achiron, Anat

“… Accurate finger function assessment is crucial for monitoring the performance of daily hand activities. However, specialized digital applications are lacking …”
Volltext

COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose von Dreyer-Alster, Sapir, Menascu, Shay, Mandel, Mathilda, Shirbint, Emanuel, Magalashvili, David, Dolev, Mark, Flechter, Shlomo, Givon, Uri, Guber, Diana, Stern, Yael, Miron, Shmuel, Polliack, Michael, Falb, Rina, Sonis, Polina, Gurevich, Michael, Achiron, Anat

“… As immunity against SARS-COV-2 wanes following first and second doses of vaccination, a third dose is administered in several countries around the world …”
Volltext

Mapping brain volume change across time in primary-progressive multiple sclerosis von Warszawer, Yehuda, Gurevich, Michael, Kerpel, Ariel, Dreyer Alster, Sapir, Nissan, Yael, Shirbint, Emanuel, Hoffmann, Chen, Achiron, Anat

“… Purpose Detection and prediction of the rate of brain volume loss with age is a significant unmet need in patients with primary progressive multiple sclerosis …”
Volltext